These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 465983)

  • 1. Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström
    Br J Urol; 1979 Jun; 51(3):175-80. PubMed ID: 465983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Odlind B; Wikström B
    J Urol; 1982 Jun; 127(6):1207-10. PubMed ID: 7087040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L; Hellgren E
    Br J Urol; 1984 Jun; 56(3):255-62. PubMed ID: 6399984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones.
    Mortensen JT; Schultz A; Ostergaard AH
    Int Urol Nephrol; 1986; 18(3):265-9. PubMed ID: 3533825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
    Jorgensen FS; Brünner S
    Scand J Urol Nephrol; 1974; 8(2):128-31. PubMed ID: 4838924
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of thiazides on the urinary calcium oxalate stone-forming potential in normal males.
    Brocks P; Christiansen C; Dirksen H; Transbøl I; Wolf H
    Scand J Urol Nephrol; 1983; 17(3):325-8. PubMed ID: 6648380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and magnesium metabolism during long-term treatment with thiazides.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol; 1981; 15(3):257-62. PubMed ID: 7323748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.
    Perlberg S; Azoury R; Garti N; Sarig S
    Br J Urol; 1985 Oct; 57(5):500-4. PubMed ID: 2998532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease.
    Ahlstrand C; Tiselius HG
    J Urol; 1981 Nov; 126(5):635-9. PubMed ID: 7299925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
    Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
    BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acclerated calcium nephrolithiasis.
    Coe FL; Parks JH; Strauss AL
    JAMA; 1980 Aug 22-29; 244(8):809-10. PubMed ID: 7392192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive therapy in patients with recurrent kidney calculi].
    Backman U; Danielson BG; Johansson G; Ljunghall S
    Lakartidningen; 1978 May; 75(19):1917-8. PubMed ID: 651452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Do thiazides prevent recurrent renal calculi? Preliminary results of a double-blind controlled study].
    Brocks P; Dahl C; Transbøl I; Wolf H
    Ugeskr Laeger; 1982 Jun; 144(23):1669-70. PubMed ID: 6753287
    [No Abstract]   [Full Text] [Related]  

  • 20. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.